Hints and tips:
Showing results for Oliver Companies, Inc.
Related Special Reports
...Influencers affiliated with Ogilvy will need to clearly say when they are being paid by a pharma company....
...The company reported increased revenue and record visitor numbers, with 1.3mn people coming to the estate each week on average....
...The company’s value had increased since then and it could now be worth roughly €4bn in a deal, one of the people said.Deliberations were at an early stage and the company could also pursue the sale of a...
...The bid for the site from Blackstone underscores the intense interest among property investors and tech companies to invest in data centres....
Success of biosimilars in lowering prices will depend on decisions from powerful pharmacy benefit managers
Seventh successive quarter of declining volumes dashes hopes for revival as high interest rates continue to bite
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...“That gives the company an incredibly profitable base business and they’ve basically reinvested a significant amount of those profits in their pipeline.”...
...Shockwave’s technology has treated approximately 400,000 patients globally, the company said....
...Other companies have also been amending their business plans following discussions with Ofwat....
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...Still, Delaware, Inc is going to have to decide whether its brand should be based on being an even-handed, dispassionate system or something more corporate-friendly, designed to keep up in a regulatory race...
...The company, which supplies 16mn people — or about 25 per cent of the population of England and Wales — is struggling to stay afloat after its shareholders refused to put more money into the heavily leveraged...
...The US drugmaker, a top-10 pharma company by sales, relies on WuXi AppTec sister company WuXi Biologics to manufacture some of the active pharmaceutical ingredients in its blockbuster cancer pill Revlimid...
...McKinsey has faced repeated claims that its work for Purdue Pharma, the maker of OxyContin, and other drug manufacturers contributed to the US opioid crisis by advising the companies on how to boost sales...
...The US biotech company reported first-quarter earnings of $3.67 a share, beating analysts’ consensus estimates of $3.44. That pushed Biogen’s shares up 4.3 per cent in early trading on Wednesday....
...Bonuses are discretionary, reflecting the logic that team members across the companies contribute....
...Oliver Roeder And the idea was that the railroad companies would sell their squares to fund construction....
...The deal, announced last month, would create a company building 22,000 homes a year with combined revenues of £7.5bn, and comes as developers weather a property market downturn....
...Perhaps the route to the City’s revival goes not via high growth tech companies, but via companies that look like Bunzl, Diploma, Intertek and Howdens. oliver.ralph@ft.com...
...“The big issue we have is that our member companies, in order to bring active ingredients and finished drug products from China to the EU, need certification from certain authorities,” Bicane said....
International Edition